HIGH-RATE OF RIFAMPICIN RESISTANCE OF MYCOBACTERIUM-TUBERCULOSIS IN THE TAIF REGION OF SAUDI-ARABIA

被引：34

作者：

JARALLAH, JS ^{[1
]}

ELIAS, AK ^{[1
]}

ALHAJJAJ, MS ^{[1
]}

BUKHARI, MS ^{[1
]}

ALSHAREEF, AHM ^{[1
]}

ALSHAMMARI, SA ^{[1
]}

机构：

[1] CHEST DIS HOSP,TAIF,SAUDI ARABIA

来源：

TUBERCLE AND LUNG DISEASE | 1992年 / 73卷 / 02期

关键词：

D O I：

10.1016/0962-8479(92)90065-R

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

This retrospective study was undertaken to determine the prevalence and pattern of resistance to antituberculosis drugs among patients with sputum-proven pulmonary tuberculosis who were seen in Taif Chest Hospital over 24 months (between June 1986 and May 1988). The overall prevalence was 22.6% and the majority (53%) were resistant to two drugs. Resistance to streptomycin was most frequent (16%) followed by rifampicin (15%). Resistance to isoniazid was surprisingly low (6.5%). 23.3% of the resistant group had previously received antituberculosis drugs as against 15.4% in the sensitive group. There was a significant association between previous therapy and resistance to antituberculosis drugs. Recommendations to reduce the problem of resistance and to improve compliance are discussed.

引用

页码：113 / 115

页数：3

共 14 条

[1]

ALORAINEY IO, 1986, SAUDI MED J, V7, P363

[2] RESISTANCE TO ANTITUBERCULOSIS DRUGS IN RIYADH, SAUDI-ARABIA [J].